Literature DB >> 24675952

"The race" to clone BRCA1.

Mary-Claire King1.   

Abstract

The existence of BRCA1 was proven in 1990 by mapping predisposition to young-onset breast cancer in families to chromosome 17q21. Knowing that such a gene existed and approximately where it lay triggered efforts by public and private groups to clone and sequence it. The press baptized the competition "the race" and reported on it in detail for the next 4 years. BRCA1 was positionally cloned in September 1994. Twenty years later, I reflect on "the race" and its consequences for breast cancer prevention and treatment.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24675952     DOI: 10.1126/science.1251900

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  34 in total

1.  Targeting progesterone signaling prevents metastatic ovarian cancer.

Authors:  Olga Kim; Eun Young Park; Sun Young Kwon; Sojin Shin; Robert E Emerson; Yong-Hyun Shin; Francesco J DeMayo; John P Lydon; Donna M Coffey; Shannon M Hawkins; Lawrence A Quilliam; Dong-Joo Cheon; Facundo M Fernández; Kenneth P Nephew; Adam R Karpf; Martin Widschwendter; Anil K Sood; Robert C Bast; Andrew K Godwin; Kathy D Miller; Chi-Heum Cho; Jaeyeon Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2020-12-01       Impact factor: 11.205

Review 2.  Homologous recombination and human health: the roles of BRCA1, BRCA2, and associated proteins.

Authors:  Rohit Prakash; Yu Zhang; Weiran Feng; Maria Jasin
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-04-01       Impact factor: 10.005

3.  The Clinical Utility of Next Generation Sequencing Results in a Community-Based Hereditary Cancer Risk Program.

Authors:  A E Bunnell; C A Garby; E J Pearson; S A Walker; L E Panos; Joanne L Blum
Journal:  J Genet Couns       Date:  2016-06-09       Impact factor: 2.537

4.  Profile of Mary-Claire King, 2014 Lasker-Koshland Special Achievement in Medical Science awardee.

Authors:  Aravinda Chakravarti
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-25       Impact factor: 11.205

5.  HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures.

Authors:  Helen Davies; Dominik Glodzik; Sandro Morganella; Lucy R Yates; Johan Staaf; Xueqing Zou; Manasa Ramakrishna; Sancha Martin; Sandrine Boyault; Anieta M Sieuwerts; Peter T Simpson; Tari A King; Keiran Raine; Jorunn E Eyfjord; Gu Kong; Åke Borg; Ewan Birney; Hendrik G Stunnenberg; Marc J van de Vijver; Anne-Lise Børresen-Dale; John W M Martens; Paul N Span; Sunil R Lakhani; Anne Vincent-Salomon; Christos Sotiriou; Andrew Tutt; Alastair M Thompson; Steven Van Laere; Andrea L Richardson; Alain Viari; Peter J Campbell; Michael R Stratton; Serena Nik-Zainal
Journal:  Nat Med       Date:  2017-03-13       Impact factor: 53.440

6.  Rapid and cost-effective high-throughput sequencing for identification of germline mutations of BRCA1 and BRCA2.

Authors:  Somayeh Ahmadloo; Hirofumi Nakaoka; Takahide Hayano; Kazuyoshi Hosomichi; Hua You; Emi Utsuno; Takafumi Sangai; Motoi Nishimura; Kazuyuki Matsushita; Akira Hata; Fumio Nomura; Ituro Inoue
Journal:  J Hum Genet       Date:  2017-02-09       Impact factor: 3.172

7.  Mitochondrial Genetics Regulate Breast Cancer Tumorigenicity and Metastatic Potential.

Authors:  Kyle P Feeley; Alexander W Bray; David G Westbrook; Larry W Johnson; Robert A Kesterson; Scott W Ballinger; Danny R Welch
Journal:  Cancer Res       Date:  2015-10-15       Impact factor: 12.701

8.  Pioneering geneticist Mary-Claire King receives the 2014 Lasker~Koshland Special Achievement Award in Medical Science.

Authors:  Jillian H Hurst
Journal:  J Clin Invest       Date:  2014-09-08       Impact factor: 14.808

9.  Expression of cancer related BRCA1 missense variants decreases MMS-induced recombination in Saccharomyces cerevisiae without altering its nuclear localization.

Authors:  Samuele Lodovichi; Martina Vitello; Tiziana Cervelli; Alvaro Galli
Journal:  Cell Cycle       Date:  2016-08-02       Impact factor: 4.534

Review 10.  Emerging roles of p53 and other tumour-suppressor genes in immune regulation.

Authors:  César Muñoz-Fontela; Anna Mandinova; Stuart A Aaronson; Sam W Lee
Journal:  Nat Rev Immunol       Date:  2016-09-26       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.